PDCD6IP
protein-codingprogrammed cell death 6 interacting protein
Gene summary
This gene encodes a protein that functions within the ESCRT pathway in the abscission stage of cytokinesis, in intralumenal endosomal vesicle formation, and in enveloped virus budding. Studies using mouse cells have shown that overexpression of this protein can block apoptosis. In addition, the product of this gene binds to the product of the PDCD6 gene, a protein required for apoptosis, in a calcium-dependent manner. This gene product also binds to endophilins, proteins that regulate membrane shape during endocytosis. Overexpression of this gene product and endophilins results in cytoplasmic vacuolization, which may be partly responsible for the protection against cell death. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. Related pseudogenes have been identified on chromosome 15. [provided by RefSeq, Jan 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~71.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0031060
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0031060
Submitter: LiferaOmics
Genetic evidence – Published PMID: 32286682 – Reports two affected brothers from one consanguineous family. One proband counted for case-level; affected sibling counted under segregation. Case-level (biallelic predicted null in AR model; homozygous; consanguinity −0.5 applied) = 1.0 Segregation (affected sibling; conservative assignment) = 0.5; Case-control = 0 Family 1 total = 1.5 PMID: 32286682 total = 1.5 PMID: 40897677– Reports one unrelated individual. Case-level (biallelic predicted null in AR model; homozygous; consanguinity −0.5 applied) = 1.0; Segregation = 0; Case-control =0 Family 2 total = 1.0 PMID: 40897677 total = 1.0 Published genetic evidence total = 2.5 / 12 Genetic evidence – Our Case Family 1 – one proband. Case-level (biallelic predicted null in AR model; homozygous; consanguinity −0.5 applied) = 1.0; Segregation = 0; Case-control = 0 Family 1 total = 1.0 Our Cases Total = 1.0 / 12 Updated Total Genetic Evidence (Published + Our Cases) Published genetic evidence: 2.5 Our additional cases: 1.0 Updated genetic total = 3.5 / 12 Experimental Evidence – Published Evidence supporting biological plausibility: PDCD6IP (ALIX) regulates the ESCRT complex involved in membrane remodeling, cytokinesis, and intracellular trafficking — mechanisms relevant to neural progenitor proliferation and brain development. Gene function / Expression / biological plausibility = 1.0 Animal/model evidence: Pdcd6ip (Alix) knockout mice demonstrate reduced brain growth consistent with a microcephaly mechanism. Animal/model evidence (brain growth relevance) = 2.5 Experimental evidence total = 3.5 / 6 Updated Overall Score Genetic evidence = 3.5 Experimental evidence = 3.5 Updated total = 7.0 / 18
Inheritance Pattern: AR
Disease ID:MONDO:0031060
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PDCD6IP variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_013374.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 2 | 2 | 8 | ||
| missense | 100 | 4 | 2 | 106 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 1 | 0 | 108 | 6 | 4 | 119 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_037506.2 | 18 | MANE Select | |
| Ensembl | ENSP00000307387.3 | 18 | MANE Select | |
| RefSeq | NP_001155901.1 | 18 | Standard | |
| RefSeq | NP_001243121.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Endocytosis - Homo sapiens (human)
- Disease
- Budding and maturation of HIV virion
- Late Phase of HIV Life Cycle
- HIV Life Cycle
Biological Process
- mitotic cytokinesis
- actomyosin contractile ring assembly
- apoptotic process
- nucleus organization
- mitotic metaphase plate congression
Molecular Function
- protein binding
- proteinase activated receptor binding
- protein homodimerization activity
- calcium-dependent protein binding
Cellular Component
- immunological synapse
- microtubule organizing center
- cytosol
- bicellular tight junction
- focal adhesion
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000457054
- Coding exons
- 18
- Length
- 71351
- Individuals with no LoFs
- 125735
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 9
- Defined
- 125744
- p
- 0.0000358
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.976 | 393 | 451 | 0.871 | 0.0000220 | 5656 |
| Missense (PolyPhen) | 72 | 115.58 | 0.62293 | 1478 | ||
| Synonymous | -0.239 | 174 | 170 | 1.02 | 0.00000871 | 1694 |
| Loss of Function | 4.85 | 9 | 43.6 | 0.207 | 0.00000210 | 571 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00012 | 0.00011 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000045 | 0.000044 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00020 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Multifunctional protein involved in endocytosis, multivesicular body biogenesis, membrane repair, cytokinesis, apoptosis and maintenance of tight junction integrity. Class E VPS protein involved in concentration and sorting of cargo proteins of the multivesicular body (MVB) for incorporation into intralumenal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome. Binds to the phospholipid lysobisphosphatidic acid (LBPA) which is abundant in MVBs internal membranes. The MVB pathway requires the sequential function of ESCRT-O, -I,-II and -III complexes (PubMed:14739459). The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis (PubMed:17853893, PubMed:17556548). Adapter for a subset of ESCRT-III proteins, such as CHMP4, to function at distinct membranes. Required for completion of cytokinesis (PubMed:17853893, PubMed:17556548, PubMed:18641129). May play a role in the regulation of both apoptosis and cell proliferation. Regulates exosome biogenesis in concert with SDC1/4 and SDCBP (PubMed:22660413). By interacting with F-actin, PARD3 and TJP1 secures the proper assembly and positioning of actomyosin-tight junction complex at the apical sides of adjacent epithelial cells that defines a spatial membrane domain essential for the maintenance of epithelial cell polarity and barrier (By similarity). {ECO:0000250|UniProtKB:Q9WU78, ECO:0000269|PubMed:14739459, ECO:0000269|PubMed:17556548, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:18641129, ECO:0000269|PubMed:22660413}.;
Recessive Scores
- pRec
- 0.125
Intolerance Scores
- LoFtool
- 0.582
- RVIS EVS
- -0.31
- RVIS percentile EVS
- 32.23
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.921
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |